FDA Adverse Event Injury Summary report: N

VERSAFITCUP DM DOUBLE MOBILITY HC LINER Ø 56/28

MDR report key: 8155028 · Received December 12, 2018

Report

Report Number
3005180920-2018-00985
Event Type
Injury
Date Received
December 12, 2018
Date of Event
November 12, 2018
Report Date
December 12, 2018
Manufacturer
MEDACTA INTERNATIONAL SA
Product Code
MEH
UDI-DI
07630030807411
PMA / PMN Number
K092265
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 1

BATCH REVIEW PERFORMED ON 12 DECEMBER 2018. LOT 167576: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 14 FEBRUARY 2017. EXPIRATION DATE: 2022-01-24. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN ALREADY SOLD WITHOUT ANY SIMILAR REPORTED EVENT. ADDITIONAL DEVICE INVOLVED IN THE ISSUE: CUP: VERSAFITCUP 01.26.56MB ACETABULAR SHELL Ø 56 (K083116), LOT 176619: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 21 FEBRUARY 2018. EXPIRATION DATE: 2023-02-11. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN ALREADY SOLD WITHOUT ANY SIMILAR REPORTED EVENT. CLINICAL EVALUATION PERFORMED BY MEDICAL AFFAIRS DIRECTOR: EARLY DISLOCATION OF A DUAL MOBILITY CUP IN PRIMARY CEMENTLESS THA. THIS EVENT MAY HAVE BEEN CAUSED BY A SUBOPTIMAL POSITION OF THE ACETABULAR CUP OR BY INSUFFICIENT TENSION OF THE SOFT TISSUES, IT IS NOT A DEVICE PROBLEM.

Description of Event or Problem · 1

THE PATIENT CAME IN DUE TO A DISLOCATION OF THE LINER FROM THE CUP 3 MONTHS AFTER PRIMARY SURGERY. THE SURGEON REVISED THE HEAD AND LINER AND THE SURGERY WAS COMPLETED SUCCESSFULLY. THE SURGEON USED A POSTERIOR APPROACH IN PRIMARY SURGERY. A BONE FRACTURE, VISIBLE ON THE X-RAYS, OCCURRED MUCH EARLIER IN THE PATIENT'S LIFE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
996923 VERSAFITCUP DM DOUBLE MOBILITY HC LINER Ø 56/28 HIP DOUBLE MOBILITY LINER MEH MEDACTA INTERNATIONAL SA 167576 07630030807411

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention